Samrat Pharmachem Limited (BOM:530125)

India flag India · Delayed Price · Currency is INR
212.55
-36.35 (-14.60%)
At close: Jun 1, 2026
Market Cap656.72M -37.8%
Revenue (ttm)2.91B +1.6%
Net Income-33.12M
EPS-10.72
Shares Out 3.09M
PE Ration/a
Forward PEn/a
Dividend1.00 (0.40%)
Ex-Dividend DateSep 18, 2025
Volume18,003
Open236.05
Previous Close248.90
Day's Range203.35 - 236.05
52-Week Range190.00 - 416.00
Beta-0.37
Analystsn/a
Price Targetn/a
Earnings DateMay 30, 2026

About Samrat Pharmachem

Samrat Pharmachem Limited engages in the manufacture and sale of pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodine, iodine monochloride, iodoquinol, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate and iodide, potassium metaper iodate, povidone iodine, sodium iodate and iodide, and sodium metaper iodate. The company serves the agrochemical, animal feed, chemical,... [Read more]

Industry Industrial Inorganic Chemicals
Founded 1992
Employees 28
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530125
Full Company Profile

Financial Performance

Financial Statements